APA (7th ed.) Citation

AW, T., JC, B., KP, P., 3rd, B. H., A, P., SF, J., . . . JR, I. (2015). A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 26(1), 58. https://doi.org/10.1093/annonc/mdu482

Chicago Style (17th ed.) Citation

AW, Tolcher, et al. "A Phase IB Trial of the Oral MEK Inhibitor Trametinib (GSK1120212) in Combination with Everolimus in Patients with Advanced Solid Tumors." Annals of Oncology : Official Journal of the European Society for Medical Oncology 26, no. 1 (2015): 58. https://doi.org/10.1093/annonc/mdu482.

MLA (9th ed.) Citation

AW, Tolcher, et al. "A Phase IB Trial of the Oral MEK Inhibitor Trametinib (GSK1120212) in Combination with Everolimus in Patients with Advanced Solid Tumors." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 26, no. 1, 2015, p. 58, https://doi.org/10.1093/annonc/mdu482.